Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | PRCP | P42785 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PPM1B | O75688 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3164291 | 1.00 | SLC6A2 (0.44) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP | |
| SCHEMBL1929065 | 1.00 | SLC6A2 (0.44) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP | |
| Hydrochloric Acid SCHEMBL6733273 | 0.98 | SLC6A2 (0.46) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP | |
| SCHEMBL5429881 | 0.98 | ALDH1A1 (0.44) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP | |
| Hydrochloric Acid SCHEMBL6954164 | 0.98 | SLC6A2 (0.46) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP | |
| SCHEMBL9438838 | 0.98 | ALDH1A1 (0.44) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP | |
| SCHEMBL9438970 | 0.98 | ALDH1A1 (0.44) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP | |
| Hydrochloric Acid SCHEMBL1282288 | 0.98 | SLC6A2 (0.46) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP | |
| SCHEMBL9439436 | 0.98 | ALDH1A1 (0.44) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP | |
| Oxalic Acid SCHEMBL29060702 | 0.95 | SLC6A2 (0.45) | SLC6A2SLC6A3SLC6A4ALDH1A1PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 483 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722187-A1 | BUILDING BLOCK FOR TRIFLUOROALKYLATION AND TRIFLUOROALKYLATION METHOD USING SAME | Seoul National University Hospital (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-3967714-B1 | VINYL ALCOHOL-AMINO ACID ESTER COPOLYMER, THEIR PREPARATION AND USES | SEKISUI CHEMICAL CO LTD (JP) | 2026-01-07 | — | — | EP | claimed |
| WO-2024242479-A1 | BUILDING BLOCK FOR TRIFLUOROALKYLATION AND TRIFLUOROALKYLATION METHOD USING SAME | 서울대학교병원 | 2024-11-28 | — | — | WO | claimed |
| CN-116969889-B | Preparation method of phenanthridine or chiral phenanthridine compound | 瑞博(杭州)医药科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116969889-A | Preparation method of phenanthridine or chiral phenanthridine compound | 瑞博(杭州)医药科技有限公司 | 2023-10-31 | — | — | CN | claimed |
| CN-115650546-A | Harmless treatment method for hermetia illucens sand | 仲恺农业工程学院 | 2023-01-31 | — | — | CN | claimed |
| CN-108239019-A | The synthetic method of one kind (2S, 5S or 5R)-N- tertbutyloxycarbonyls -5- hydroxyls -2-piperidinecarboxylic acid ethyl ester | 浙江医药股份有限公司新昌制药厂 | 2018-07-03 | — | — | CN | claimed |
| CN-106810769-A | A kind of low temperature resistant PP composite material and preparation method thereof | 宁夏润龙包装新材料股份有限公司 | 2017-06-09 | — | — | CN | claimed |
| US-20070232559-A1 | 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2007-10-04 | — | — | US | claimed |
| EP-0471592-B1 | Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids | DOW CHEMICAL CO (US) | 1995-08-09 | — | — | EP | claimed |
| EP-0552360-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-07-28 | — | — | EP | claimed |
| EP-0538380-A1 | NEMATICIDAL N-(SULFONYL)PHOSPHONAMIDOTHIOATES AND DITHIOATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-04-28 | — | — | EP | claimed |
| WO-1993003825-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-03-04 | — | — | WO | claimed |
| US-5167941-A | Sulfur dioxide; cationic polyelectrolyte stabilizers | THE DOW CHEMICAL COMPANY (US) | 1992-12-01 | — | — | US | claimed |
| EP-0471592-A2 | Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids | THE DOW CHEMICAL COMPANY (US) | 1992-02-19 | — | — | EP | claimed |
| US-4925849-A | DIURETICS, HYPOTENSIVE AGENTS, CARIOTONIC AGENTS AND ANTIEDEMIC AGENTS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-05-15 | — | — | US | claimed |
| EP-0188805-B1 | 1,3-DITHIOLE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-09-06 | — | — | EP | claimed |
| EP-0299209-A2 | Pyrazolopyridine compound and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-01-18 | — | — | EP | claimed |
| US-4737494-A | 2-YLIDENE AMMONIUM COMPOUNDS USED IN TREATING LIVER DISEASES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1988-04-12 | — | — | US | claimed |
| EP-0188805-A1 | 1,3-Dithiole derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1986-07-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232559-A1 | 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF | ADORA2A, ADORA3, ADORA1 | SLC6A2 786/4885SLC6A3 832/4885SLC6A4 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.